Abstract

G protein-coupled receptor kinases (GRKs) constitute a family of seven mammalian serine/threonine protein kinases that phosphorylate/modify agonist-bound or activated G protein-coupled receptors (GPCRs) as their primary substrates. GRK4 is distinguished from other members of the GPCR family by its constitutive activity and limited tissue expression. Our previous study found that GRK4 variants (A142V, A486V and R65L) increases GRK4 activity; A142V transgenic mice develop hypertension with impaired sodium excretion by impairment of renal D 1 dopamine receptor and augmented renal AT 1 receptor expression and function. Whether there is GRK4 in the artery is not known. Our preliminary study found GRK4 expression in the artery, determined by immunoblotting and histochemistry. We hypothesize that GRK4 might also regulate AT 1 receptor expression and function in vascular smooth muscle cells (VSMCs). A10 cells, an embryonic thoracic aortic smooth muscle cell lines, were transfected with A142V in this study. It resulted A142V increased AT 1 receptor protein and mRNA expressions in A10 cells, meanwhile, decreased AT 1 receptor phosphorylation. The regulation of A142V on AT 1 receptor is physiological significance, because the angiotensin II-mediated VSMC proliferation was greater in the A142V transfected cells than in the control cells. Moreover, the vasoconstrictive effect of angiotensin II was greater in A142 transgenic mice than control mice. The above-mentioned phenomenon is confirmed by siRNA, GRK4 siRNA decreased AT 1 receptor expression, increased AT 1 receptor phosphorylation in primary cultured VSMCs from spontaneously hypertensive rats. Our further study found that there was co-localization between GRK4 and AT 1 receptor in A10 cells, transfected with A142V increased the linkage of GRK4/AT 1 receptor. It indicated that arterial GRK4 regulation of AT 1 receptor expression and function, which might be engaged in the pathogenesis of hypertension.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.